How is prostatic artery embolization (PAE) used in the treatment of benign prostatic hyperplasia (BPH)?

Updated: Feb 19, 2021
  • Author: Levi A Deters, MD; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print

The incidental discovery that the use of selective prostatic arty embolization (PAE) to control bleeding secondary to BPH resulted in improved LUTS led to investigation of its direct use in the relief of LUTS in patients with BPH. Although a growing body of evidence supports its safety and efficacy, PAE has yet to be established as a standard-of-care treatment option. [43, 44] A systematic review that included 16 studies concluded that PAE should still be considered experimental. [45]  The 2018 AUA guideline does not recommend PAE outside the context of a clinical trial. [1]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!